Epo is involved in angiogenesis in human glioma

Beatrice Nico, Tiziana Annese, Diego Guidolin, Nicoletta Finato, Enrico Crivellato, Domenico Ribatti

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

In this study, the extent of angiogenesis, evaluated as microvascular density, and the immunoreactivity of tumor cells to erythropoietin (Epo) and of endothelial cells to Epo receptor (EpoR) have been correlated in human glioma specimens, and the effect of anti-Epo antibody on glioma-induced angiogenesis in vivo in the chick embryo chorioallantoic membrane (CAM) has been investigated. Results show that: (1) Epo/EpoR expression correlates with angiogenesis, (2) in the CAM assay, tumor bioptic specimens induce a strong angiogenic response, comparable to that induced by VEGF, and (3) an anti-Epo antibody co-administered with tumor bioptic specimens significantly inhibits the angiogenic response. These findings suggest the presence of a loop in the Epo/EpoR system, i.e. Epo is secreted by glioma tumor cells and it affects glioma vascular endothelial cells via its receptor and promotes angiogenesis in a paracrine manner. Moreover, as demonstrated by in vivo experiments, Epo is responsible for the strong angiogenic response induced by human glioma bioptic specimens, because an anti-Epo antibody is able to significantly inhibit this response.

Original languageEnglish
Pages (from-to)51-58
Number of pages8
JournalJournal of Neuro-Oncology
Volume102
Issue number1
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Erythropoietin
Glioma
Erythropoietin Receptors
Chorioallantoic Membrane
Anti-Idiotypic Antibodies
Neoplasms
Endothelial Cells
Chick Embryo
Vascular Endothelial Growth Factor A

Keywords

  • Angiogenesis
  • Chorioallantoic membrane
  • Epo
  • EpoR
  • Human glioma

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Nico, B., Annese, T., Guidolin, D., Finato, N., Crivellato, E., & Ribatti, D. (2011). Epo is involved in angiogenesis in human glioma. Journal of Neuro-Oncology, 102(1), 51-58. https://doi.org/10.1007/s11060-010-0294-6

Epo is involved in angiogenesis in human glioma. / Nico, Beatrice; Annese, Tiziana; Guidolin, Diego; Finato, Nicoletta; Crivellato, Enrico; Ribatti, Domenico.

In: Journal of Neuro-Oncology, Vol. 102, No. 1, 03.2011, p. 51-58.

Research output: Contribution to journalArticle

Nico, B, Annese, T, Guidolin, D, Finato, N, Crivellato, E & Ribatti, D 2011, 'Epo is involved in angiogenesis in human glioma', Journal of Neuro-Oncology, vol. 102, no. 1, pp. 51-58. https://doi.org/10.1007/s11060-010-0294-6
Nico B, Annese T, Guidolin D, Finato N, Crivellato E, Ribatti D. Epo is involved in angiogenesis in human glioma. Journal of Neuro-Oncology. 2011 Mar;102(1):51-58. https://doi.org/10.1007/s11060-010-0294-6
Nico, Beatrice ; Annese, Tiziana ; Guidolin, Diego ; Finato, Nicoletta ; Crivellato, Enrico ; Ribatti, Domenico. / Epo is involved in angiogenesis in human glioma. In: Journal of Neuro-Oncology. 2011 ; Vol. 102, No. 1. pp. 51-58.
@article{ff563e1641084925a7e03c9cceb7a318,
title = "Epo is involved in angiogenesis in human glioma",
abstract = "In this study, the extent of angiogenesis, evaluated as microvascular density, and the immunoreactivity of tumor cells to erythropoietin (Epo) and of endothelial cells to Epo receptor (EpoR) have been correlated in human glioma specimens, and the effect of anti-Epo antibody on glioma-induced angiogenesis in vivo in the chick embryo chorioallantoic membrane (CAM) has been investigated. Results show that: (1) Epo/EpoR expression correlates with angiogenesis, (2) in the CAM assay, tumor bioptic specimens induce a strong angiogenic response, comparable to that induced by VEGF, and (3) an anti-Epo antibody co-administered with tumor bioptic specimens significantly inhibits the angiogenic response. These findings suggest the presence of a loop in the Epo/EpoR system, i.e. Epo is secreted by glioma tumor cells and it affects glioma vascular endothelial cells via its receptor and promotes angiogenesis in a paracrine manner. Moreover, as demonstrated by in vivo experiments, Epo is responsible for the strong angiogenic response induced by human glioma bioptic specimens, because an anti-Epo antibody is able to significantly inhibit this response.",
keywords = "Angiogenesis, Chorioallantoic membrane, Epo, EpoR, Human glioma",
author = "Beatrice Nico and Tiziana Annese and Diego Guidolin and Nicoletta Finato and Enrico Crivellato and Domenico Ribatti",
year = "2011",
month = "3",
doi = "10.1007/s11060-010-0294-6",
language = "English",
volume = "102",
pages = "51--58",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - Epo is involved in angiogenesis in human glioma

AU - Nico, Beatrice

AU - Annese, Tiziana

AU - Guidolin, Diego

AU - Finato, Nicoletta

AU - Crivellato, Enrico

AU - Ribatti, Domenico

PY - 2011/3

Y1 - 2011/3

N2 - In this study, the extent of angiogenesis, evaluated as microvascular density, and the immunoreactivity of tumor cells to erythropoietin (Epo) and of endothelial cells to Epo receptor (EpoR) have been correlated in human glioma specimens, and the effect of anti-Epo antibody on glioma-induced angiogenesis in vivo in the chick embryo chorioallantoic membrane (CAM) has been investigated. Results show that: (1) Epo/EpoR expression correlates with angiogenesis, (2) in the CAM assay, tumor bioptic specimens induce a strong angiogenic response, comparable to that induced by VEGF, and (3) an anti-Epo antibody co-administered with tumor bioptic specimens significantly inhibits the angiogenic response. These findings suggest the presence of a loop in the Epo/EpoR system, i.e. Epo is secreted by glioma tumor cells and it affects glioma vascular endothelial cells via its receptor and promotes angiogenesis in a paracrine manner. Moreover, as demonstrated by in vivo experiments, Epo is responsible for the strong angiogenic response induced by human glioma bioptic specimens, because an anti-Epo antibody is able to significantly inhibit this response.

AB - In this study, the extent of angiogenesis, evaluated as microvascular density, and the immunoreactivity of tumor cells to erythropoietin (Epo) and of endothelial cells to Epo receptor (EpoR) have been correlated in human glioma specimens, and the effect of anti-Epo antibody on glioma-induced angiogenesis in vivo in the chick embryo chorioallantoic membrane (CAM) has been investigated. Results show that: (1) Epo/EpoR expression correlates with angiogenesis, (2) in the CAM assay, tumor bioptic specimens induce a strong angiogenic response, comparable to that induced by VEGF, and (3) an anti-Epo antibody co-administered with tumor bioptic specimens significantly inhibits the angiogenic response. These findings suggest the presence of a loop in the Epo/EpoR system, i.e. Epo is secreted by glioma tumor cells and it affects glioma vascular endothelial cells via its receptor and promotes angiogenesis in a paracrine manner. Moreover, as demonstrated by in vivo experiments, Epo is responsible for the strong angiogenic response induced by human glioma bioptic specimens, because an anti-Epo antibody is able to significantly inhibit this response.

KW - Angiogenesis

KW - Chorioallantoic membrane

KW - Epo

KW - EpoR

KW - Human glioma

UR - http://www.scopus.com/inward/record.url?scp=79952188040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952188040&partnerID=8YFLogxK

U2 - 10.1007/s11060-010-0294-6

DO - 10.1007/s11060-010-0294-6

M3 - Article

C2 - 20614229

AN - SCOPUS:79952188040

VL - 102

SP - 51

EP - 58

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -